Ledger.Open graph →

SEC Form D · filed September 26, 2024

Summit Therapeutics Inc

Offering

$235.0M

Sold

$235.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Miami, FL

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Robert Booth · Miami, FLDirector Kenneth Clark · Miami, FLDirector Yu Xia · Miami, FLDirector Manmeet Soni · Miami, FLExec · Director Alessandra Cesano · Miami, FLDirector Mostafa Ronaghi · Miami, FLDirector Mahkam Zanganeh · Miami, FLExec · Director Jeff Huber · Mukilteo, WADirector Alessandra Cesano · Miami, FLDirector Kenneth Clark · Miami, FLDirector Robert Booth · Miami, FLDirector Mostafa Ronaghi · Miami, FLDirector Yu Xia · Miami, FLDirector Mahkam Zanganeh · Miami, FLExec · Director Manmeet Soni · Miami, FLExec · Director Robert Duggan · Palo Alto, CAExec · Director Phillipe Bucher · Zurich, V8Director Zachary Wolfe · Los Angeles, CAExec · Director Alex P. Pease · New York, NYDirector Spencer Brown · Westport, CTExec · Director Kyle York · Manchester, NHDirector James Mccloud · Southport, CTDirector Thomas Nye · Cedarburg, WIDirector Robert Duggan · Palo Alto, CAExec · Director Jeff Huber · Allston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗